Introducing G4

An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility.

Designed for Superior Performance

Icon Bolt

1.6 Billion Reads1
up to
480 Gb

Delivers more data per day than any benchtop sequencer.

Icon Speed

<24 Hour
Run Times

Raising the bar with industry-leading run times across applications.

Icon Split

4 Flow Cells
16 Lanes

Intentionally designed to maximize operational efficiency.

Innovation with Intention

Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. 

Watch Video

Play Video

A Singular Focus

At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine.

  • We are forward-thinking and driven by impactful innovation.
    About Us
  • We are purposeful and collaborative in our approach. We are advancing genomics, together.
    Join Us
A Singular Focus
1 Up to 4.8 billion reads with Max Read Kits and 480 Gb for F3 2×150 bp for single cell RNA sequencing. System throughput depends on sequencing application and flow cell.

Drew Spaventa

Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.

Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.

Max Reads Application Note